Olivia Manser | executive |
Christian Itin | executive |
Robert Dolski | executive |
Dingding Shi | analyst |
James Shin | analyst |
Asthika Goonewardene | analyst |
Matthew Phipps | analyst |
Gil Blum | analyst |
Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics' call to discuss its First Quarter 2024 Financial Results and Business Update.
As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Olivia Manser. Please go ahead.
Thanks, Tanya.